Dr. Shi Junjie is a medicinal chemist and drug discovery expert with a strong academic background and industry experience in central nervous system (CNS) drug development. He graduated with a ‌Bachelor of Medicine‌ degree from ‌China Pharmaceutical University‌ and later obtained a ‌Ph.D.‌ from ‌East China Normal University‌, specializing in ‌medicinal chemistry and molecular design‌, particularly ligands targeting ‌sigma receptors‌ and ‌cannabinoid receptors‌. Following his Ph.D., Dr. Shi joined ‌Nanjing University School of Medicine‌ for postdoctoral research, where he expanded his expertise in ‌CNS pharmacology‌. He then served as the ‌Manager of Medicinal Chemistry‌ at ‌Jiangsu Nhwa Pharmaceutical Co., Ltd.‌, leading drug discovery efforts for ‌CNS-targeted therapies‌. His research focused on multi-target ligands for ‌5-HT, opioid, GABA, and ion channels‌, addressing therapeutic areas like ‌anesthesia, pain management, depression, and epilepsy‌. Dr. Shi’s contributions include advancing several molecular candidates to the ‌PCC and ‌IND stages, demonstrating his ability to bridge academic innovation with industry development. His work integrates ‌molecular design, pharmacological evaluation, and clinical translation‌, making him a key contributor to CNS drug discovery.